Home    Back

Npc-12g gel    (DrugBank: -)

2 diseases
IDDisease name (Link within this page)Number of trials
34Neurofibromatosis1
158Tuberous sclerosis2

34. Neurofibromatosis    [ 120 clinical trials,   182 drugs,   (DrugBank: 72 drugs),   84 drug target genes,   194 drug target pathways]
Searched query = "Neurofibromatosis", "NF1", "von Recklinghausen disease", "NF2"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 120 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04461886
(ClinicalTrials.gov)		July 8, 20203/7/2020A Long-term Study of NPC-12G Gel in Neurofibromatosis Type IA Long-term Study of NPC-12G Gel in Neurofibromatosis Type INeurofibromatosisDrug: NPC-12G gelNobelpharmaNULLRecruiting3 YearsN/AAll100Phase 3Japan

158. Tuberous sclerosis    [ 100 clinical trials,   62 drugs,   (DrugBank: 16 drugs),   35 drug target genes,   115 drug target pathways]
Searched query = "Tuberous sclerosis", "Tuberous sclerosis complex"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 100 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02634931
(ClinicalTrials.gov)		December 201516/12/2015Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis ComplexA Long-term, Single-arm, Open-label Trial of NPC-12G (Topical Formulation of Sirolimus) to Angiofibroma and Other Skin Lesions in Patients With Tuberous Sclerosis ComplexTuberous Sclerosis;Angiofibroma;Hypomelanotic Macule;PlaqueDrug: NPC-12G gelNobelpharmaNULLCompleted3 YearsN/AAll94Phase 3Japan
2NCT02635789
(ClinicalTrials.gov)		December 201515/12/2015Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)A Double-blind, Randomized, Placebo-controlled Phase III Trial to Investigate the Efficacy and Safety of NPC-12G Gel (Topical Formulation of Sirolimus) to Angiofibroma and Other Skin Lesions in Patients With Tuberous Sclerosis ComplexTuberous Sclerosis;Angiofibroma;Hypomelanotic Macule;PlaqueDrug: NPC-12G gel;Drug: Placebo gelNobelpharmaNULLCompleted3 YearsN/AAll62Phase 3Japan